盟科药业(688373.SH)：拟继续使用不超5亿元闲置募集资金进行现金管理

Group 1 - The company, Amgen Pharmaceutical (688373.SH), plans to continue using up to RMB 500 million of temporarily idle raised funds for cash management [1] - The maximum duration for each transaction will not exceed 12 months, effective from the date of approval by the company's board of directors [1] - Within the specified limit and validity period, the funds can be used in a rolling manner [1]